Public Genome Infrastructure Governance

Introduction

Public Genome Infrastructure Governance refers to the legal, ethical, and institutional framework governing the public infrastructure used to collect, sequence, store, analyze, and share genomic information. This infrastructure may include national genome databases, biobanks, sequencing laboratories, bioinformatics platforms, and secure data-sharing systems.

The concept is an emerging governance principle rather than a single codified doctrine. Its purpose is to ensure that publicly supported genomic resources promote scientific research and public health while protecting privacy, informed consent, data security, equality, and community interests.

In India, initiatives such as GenomeIndia and the Indian Biological Data Centre (IBDC) illustrate the growing importance of public genomic infrastructure. GenomeIndia data has been made available to researchers through established data-sharing arrangements.

Press Information Bureau+1

Legal and Constitutional Framework

Article 21 of the Constitution protects life, personal liberty, dignity, and privacy. Article 14 requires equality and non-arbitrary state action. These constitutional principles are relevant when public institutions collect or manage sensitive genetic information.

Effective infrastructure governance requires:

Privacy and data security: Genetic data should be protected against unauthorized access, disclosure, and misuse.

Informed consent: Participants should understand the purpose of sample collection, storage, sharing, and future research.

Controlled access: Researchers should receive access according to transparent criteria and appropriate safeguards.

Data quality and integrity: Institutions should maintain accurate records, secure systems, and reliable scientific processes.

Fair benefit sharing: Communities and participants should not be unfairly excluded from benefits arising from publicly funded genomic research.

Accountability: Data custodians and regulators should be subject to independent oversight and effective complaint mechanisms.

These principles are reflected in India’s biological-data sharing initiatives and ethical guidance on biobanking and genomic research.

static.investindia.gov.in+2

Important Case Laws

1. Justice K.S. Puttaswamy v. Union of India (2017) 10 SCC 1

The Supreme Court recognized privacy as a fundamental right, including informational privacy and personal autonomy. It held that restrictions on privacy must have a legal basis, a legitimate purpose, and satisfy proportionality.

Live Law

Relevance: Public genome databases may contain sensitive information about health, ancestry, and biological relatives. This judgment supports legal safeguards for collecting, storing, accessing, and sharing genomic data.

2. Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1

The Supreme Court held that valid medical consent must be voluntary and based on adequate information. Consent to one procedure does not automatically authorize a materially different procedure.

Relevance: Participants donating biological samples or genomic data should receive clear information about future research, data sharing, and possible secondary uses. Consent should not be treated as unlimited permission for every future use.

3. A.P. Pollution Control Board v. Prof. M.V. Nayudu (1999) 2 SCC 718

The Supreme Court emphasized the importance of scientific expertise in environmental decision-making and recognized the difficulty of evaluating complex technical evidence.

Relevance: Public genomic infrastructure requires competent scientific and technical oversight. Data access, storage security, analytical standards, and risk assessments should be evaluated by qualified bodies rather than being left to arbitrary administrative decisions.

4. Gene Campaign v. Union of India (2024) 2024 INSC 545

The Supreme Court considered challenges concerning genetically modified mustard, DMH-11. It recognized that regulatory decisions concerning genetically modified organisms are subject to judicial review and directed the Union Government to formulate a national policy on GM crops. The judges differed on the validity of the specific approval, which was referred for further consideration.

SCI API+1

Relevance: Although the case concerns genetically modified crops rather than genomic databases, it demonstrates that biotechnology-related public decisions require regulatory scrutiny, scientific assessment, and accountability.

Major Governance Challenges

Consent for future use: Genomic databases may be used for research not anticipated when samples were collected.

Re-identification risk: Removing names does not always prevent identification through genetic or linked information.

Access and equity: Transparent access rules are necessary to avoid unfair advantages for selected researchers or commercial entities.

Community interests: Genomic findings may affect entire populations, including communities whose genetic characteristics are studied.

Cybersecurity: Public databases require strong access controls, encryption, incident reporting, and secure backups.

Benefit sharing: Publicly funded genomic research should generate fair scientific and social benefits.

Conclusion

Public Genome Infrastructure Governance seeks to ensure that national genomic databases, biobanks, laboratories, and data-sharing systems operate safely, ethically, and transparently. Although Indian courts have not established a specific doctrine under this name, constitutional privacy, informed-consent principles, and judicial review provide important legal foundations.

The cases of Puttaswamy, Samira Kohli, A.P. Pollution Control Board, and Gene Campaign offer relevant principles for protecting genomic data and ensuring scientific accountability. A sound governance framework must combine privacy safeguards, informed consent, secure infrastructure, fair access, independent oversight, and public accountability so that genomic resources benefit society without undermining individual or community rights.